Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_3

33%

Ph not_applicable

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 3Large-scale testing

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(1)

Other(2)

Detailed Status

unknown2

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (33.3%)

N/A2 (66.7%)

Trials by Status

unknown267%

completed133%

Recent Activity

0 active trials

Showing 3 of 3

unknownnot_applicable

To Evaluate the Efficacy and Safety of MaxioCel Versus Aquacel Extra for the Management of Chronic Wounds

NCT05312762

unknownnot_applicable

Assessment of Efficacy & Safety for a New Wound Dressing Urgo 310 3166 in the Local Treatment of VLU or Mixed Leg Ulcers

NCT02583958

completedphase_3

Study to Evaluate the Performance of AQUACEL® Extra™ in Venous Leg Ulcers

NCT01591434

Clinical Trials (3)

Showing 3 of 3 trials

NCT05312762Not Applicable

To Evaluate the Efficacy and Safety of MaxioCel Versus Aquacel Extra for the Management of Chronic Wounds

Unknown

NCT02583958Not Applicable

Assessment of Efficacy & Safety for a New Wound Dressing Urgo 310 3166 in the Local Treatment of VLU or Mixed Leg Ulcers

Unknown

NCT01591434Phase 3

Study to Evaluate the Performance of AQUACEL® Extra™ in Venous Leg Ulcers

Completed

All 3 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 3